Keywords: Acute kidney injury; Antimicrobial; Cefepime; Hematopoietic cell transplantation; Piperacillin/tazobactam; Vancomycin;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Cystitis; Antibiogram; Escherichia coli; Cefaclor; ABPC; ampicillin; PIPC; piperacillin; CEZ; cefazolin; CPDX-PR; cefpodoxime proxetil; CAZ; ceftazidime; IPM/CS; imipenem cilastatin; MEPM; meropenem; AMK; amikacin; GM; gentamicin; MINO; minocycline; ABPC/
Keywords: Febrile neutropenia; Randomized trial; Cefepime; Cefozopran; Meropenem and imipenem–cilastatin
Short communication: Extended-spectrum AmpC-producing Escherichia coli from milk and feces in dairy farms in Brazil
Keywords: AmpC; cefepime; chromosomal gene;
Spread of multidrug-resistant Escherichia coli harboring integron via swine farm waste water treatment plant
Keywords: AMP; ampicillin; AMC; amoxicillin/clavulanic acid; CZ; cefazolin; FOX; cefoxitin; CTX; cefotaxime; CAZ; ceftazidime; FEP; cefepime; AZT; aztreonam; AK; amikacin; CIP; ciprofloxacin; GN; gentamicin; MDR; multi-drug resistance; ESBL; extended-spectrum β-la
Decrease in the prevalence of extended-spectrum cephalosporin-resistant Salmonella following cessation of ceftiofur use by the Japanese poultry industry
Keywords: CAZ; ceftazidime; CEF; ceftiofur; CFIX; cefixime; CFPM; cefepime; CFX; cefoxitin; CLSI; Clinical and Laboratory Standards Institute; CMZ; cefmetazole; CPD; cefpodoxime; CTT; cefotetan; CTX; cefotaxime; CVA; clavulanic acid; DDBJ; DNA Data Bank of Japan; E
Cefepime versus carbapenems for the treatment of urinary tract infections caused by extended-spectrum β-lactamase-producing enterobacteriaceae
Keywords: Cefepime; Carbapenems; Extended-spectrum β-lactamase; ESBL; Enterobacteriaceae; Urinary tract infection;
Correlation between cefepime utilisation and Pseudomonas aeruginosa resistance rates to β-lactams and carbapenems in patients with healthcare-associated infections
Keywords: Cefepime; Pseudomonas aeruginosa; Resistance rate;
Comparison of acute kidney injury risk associated with vancomycin and concomitant piperacillin/tazobactam or cefepime in the intensive care unit
Keywords: Acute kidney injury; Cefepime; Critical care; Intensive care unit; Nephrotoxicity; Piperacillin tazobactam; Vancomycin;
Cefepime induced neurotoxicity: A case series and review of the literature
Keywords: Cefepime; Neurotoxicity; Seizures; Myoclonic activity; Expressive aphasia; Diffuse slowing; Impaired renal function;
Defining the impact of severity of illness on time above the MIC threshold for cefepime in Gram-negative bacteraemia: a 'Goldilocks' window
Keywords: Cefepime; Pharmacokinetic/pharmacodynamic; APACHE II score;
Enhanced activity of cefepime-tazobactam (WCK 4282) against KPC-producing Enterobacteriaceae when tested in media supplemented with human serum or sodium chloride
Keywords: Tazobactam; KPC; Beta-lactamase inhibitor combination; Susceptibility testing; Enterobacteriaceae; Cefepime;
Population pharmacokinetics of cefepime in febrile neutropenia: implications for dose-dependent susceptibility and contemporary dosing regimens
Keywords: Cefepime; β-Lactams; Pharmacology; Population pharmacokinetics; Febrile neutropenia;
A propensity score-matched analysis of the impact of minimum inhibitory concentration on mortality in patients with Pseudomonas aeruginosa bacteremia treated with cefepime or ceftazidime
Keywords: Pseudomonas aeruginosa; Cefepime; Ceftazidime; Mic; Bacteremia;
Cefepime-induced encephalopathy in end-stage renal disease patients
Keywords: CFPM; cefepime; CFPMIE; cefepime-induced encephalopathy; Cefepime; Cefepime-induced encephalopathy; Dose adjustment; Encephalopathy; End-stage renal disease; Neurotoxicity; Renal dose;
Cefepime plasma concentrations and clinical toxicity: a retrospective cohort study
Keywords: β-Lactam therapeutic drug monitoring; Cefepime; Plasma concentration; Toxicity; Toxicity threshold;
Impact of CLSI and EUCAST Cefepime breakpoint changes on the susceptibility reporting for Enterobacteriaceae
Keywords: Cefepime; Enterobacteriaceae; AmpC; ESBL;
The efficacy and safety of cefepime or meropenem in the treatment of febrile neutropenia in patients with lung cancer. A randomized phase II study
Keywords: Lung cancer; Febrile neutropenia; Cefepime; Meropenem
Use of aztreonam in association with cefepime for the treatment of nosocomial infections due to multidrug-resistant strains of Pseudomonas aeruginosa to β-lactams in ICU patients: A pilot study
Keywords: Cefepime; Aztreonam; AmpC; Pseudomonas aeruginosa; Multiresistant; Pneumonia
Relationship between the distribution of cefepime minimum inhibitory concentrations and detection of extended-spectrum β-lactamase production among clinically important Enterobacteriaceae isolates obtained from patients in intensive care units in Taiwan:
Keywords: Cefepime; Clinical and Laboratory Standards Institute; Enterobacteriaceae; Extended-spectrum β-lactamase; Surveillance for Monitoring Antimicrobial Resistance in Taiwan
Cefepime combined with amoxicillin/clavulanic acid: a new choice for the KPC-producing K. pneumoniae infection
Keywords: Cefepime; Amoxicillin/clavulanic acid; Klebsiella pneumoniae; KPC; Prospective study; Tigecycline
Application of Savitzky–Golay differentiation filters and Fourier functions to simultaneous determination of cefepime and the co-administered drug, levofloxacin, in spiked human plasma
Keywords: Cefepime; Levofloxacin; Spectrophotometry; Savitzky–Golay; Fourier; Plasma
Evaluation of clinical outcomes in patients with Gram-negative bloodstream infections according to cefepime MIC
Keywords: Cefepime; Gram-negative bacteria; Bloodstream infection; Minimum inhibitory concentration; Mortality
Risk factors for bloodstream infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: A focus on antimicrobials including cefepime
Keywords: Extended-spectrum β-lactamase; ESBL; Bloodstream; Bloodstream infection; Risk factors; Escherichia coli; E coli; Klebsiella pneumoniae; K pneumoniae; Cefepime; Antimicrobials;
Continuous versus intermittent infusion of cefepime in neurosurgical patients with post-operative intracranial infections
Keywords: Cefepime; Continuous infusion; Intermittent infusion; Intracranial infection; Minimum inhibitory concentration
Cefepime monotherapy for febrile neutropenia in patients with lung cancer
Keywords: Cefepime; Febrile neutropenia; Chemotherapy; Lung cancer
When Pharmacodynamics Trump Costs: An Antimicrobial Stewardship Program’s Approach to Selecting Optimal Antimicrobial Agents
Keywords: antimicrobial stewardship; carbapenems; cefepime; cost; pharmacodynamics; prolonged infusions
Randomized controlled trial comparing ciprofloxacin and cefepime in febrile neutropenic patients with hematological malignancies
Keywords: Febrile neutropenia; Hematological malignancy; Randomized controlled trial; Ciprofloxacin; Cefepime
Characterisation and clinical features of Enterobacter cloacae bloodstream infections occurring at a tertiary care university hospital in Switzerland: is cefepime adequate therapy?
Keywords: Cefepime; Bacteraemia; Outcome; Enterobacter; AmpC; AmpD
Direct cefepime determination in human milk using solid mercury amalgam electrode manufactured with silver nanoparticles
Keywords: Cefepime; β-lactams; Human milk; Electroanalysis; Silver solid amalgam electrode;
Antibiotic therapy for inducible AmpC β-lactamase-producing Gram-negative bacilli: what are the alternatives to carbapenems, quinolones and aminoglycosides?
Keywords: Enterobacter; Citrobacter; Serratia; Cefepime; Piperacillin/tazobactam; Trimethoprim/sulfamethoxazole; Ceftriaxone; Cefotaxime
Cefepime-related encephalopathy in peritoneal dialysis patients
Keywords: Cefepime; Electroencephalogram; Encephalopathy; Peritoneal dialysis
Steady-state pharmacokinetics and pharmacodynamics of cefepime administered by prolonged infusion in hospitalised patients
Keywords: Cefepime; Pharmacokinetics; Pharmacodynamics; Monte Carlo
Mechanisms of resistance in clinical isolates of Pseudomonas aeruginosa less susceptible to cefepime than to ceftazidime
Keywords: Cefepime; efflux pumps; PSE-1; Pseudomonas aeruginosa; resistance
Newer Beta-lactam Antibiotics: Doripenem, Ceftobiprole, Ceftaroline, and Cefepime
Keywords: Beta-lactam; Doripenem; Ceftobiprole; Ceftaroline; Cefepime;
Maternal and fetal blood levels of moxifloxacin, levofloxacin, cefepime and cefoperazone
Keywords: Moxifloxacin; Levofloxacin; Cefepime; Cefoperazone; Antibiotics; Fetal blood; Maternal blood
The novel sensitive and high throughput determination of cefepime in mouse plasma by SCX-LC/MS/MS method following off-line μElution 96-well solid-phase extraction to support systemic antibiotic programs
Keywords: Cefepime; μElution SPE; SCX; LC/MS/MS; Mouse plasma; Pharmacokinetics
Newer Beta-lactam Antibiotics: Doripenem, Ceftobiprole, Ceftaroline, and Cefepime
Keywords: Beta-lactam; Doripenem; Ceftobiprole; Ceftaroline; Cefepime;
β-Lactams without a suicide inhibitor
Keywords: Cefepime; extended-spectrum β-lactamases; temocillin; third-generation cephalosporins; treatment; review
Emergence of a cefepime- and cefpirome-resistant Citrobacter freundii clinical isolate harbouring a novel chromosomally encoded AmpC β-lactamase, CMY-37
Keywords: AmpC; β-Lactamase; Citrobacter freundii; Cefepime; Cefpirome
Peritoneal pharmacokinetics of cefepime in laparotomy patients with inflammatory bowel disease, and dosage considerations for surgical intra-abdominal infections based on pharmacodynamic assessment
Keywords: Cefepime; Peritoneal fluid; Pharmacokinetics; Pharmacodynamics;
Comparative activities of cefepime and piperacillin/tazobactam tested against a global collection of Escherichia coli and Klebsiella spp. with an ESBL phenotype
Keywords: ESBL; Klebsiella; Escherichia coli; Cefepime; Piperacillin/tazobactam
Pharmacokinetic and pharmacodynamic profiling of cefepime in plasma and peritoneal fluid of abdominal surgery patients
Keywords: Cefepime; Pharmacokinetics; Pharmacodynamics; Peritoneal fluid; Monte Carlo simulation
Simultaneous determination of cefepime, vancomycin and imipenem in human plasma of burn patients by high-performance liquid chromatography
Keywords: Cefepime; Vancomycin; Imipenem; Liquid–liquid chromatography
Bactericidal activity of cefepime and ceftriaxone tested against Streptococcus pneumoniae
Keywords: Cefepime; Ceftriaxone; Streptococcus pneumoniae; Bactericidal activity; Time kill curve; Tolerance
Cefepime pharmacodynamics in patients with extended spectrum β-lactamase (ESBL) and non-ESBL infections
Keywords: Extended spectrum β-Lactamases; Cefepime; Pharmacodynamics; Resistance; Breakpoint; Monte Carlo Simulation; continuous infusion
Comparison of the probability of target attainment between ceftriaxone and cefepime in the cerebrospinal fluid and serum against Streptococcus pneumoniae
Keywords: Monte Carlo simulation; Population PK; CSF; Ceftriaxone; Cefepime
Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998–2004)
Keywords: Cephalosporins; Cefepime; Ceftriaxone; Pediatrics; North America; SENTRY Program
Cefepime versus ceftazidime: considerations for empirical use in critically ill patients
Keywords: Cefepime; Ceftazidime; Critical illness; Spectrum of activity; Antibiotic resistance
In vivo selection of Enterobacter aerogenes with reduced susceptibility to cefepime and carbapenems associated with decreased expression of a 40 kDa outer membrane protein and hyperproduction of AmpC β-lactamase
Keywords: Enterobacter aerogenes; AmpC; Outer membrane protein; Cefepime; Carbapenems